Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular matrix (ECM) proteins and wound exudate components constitute the structural and fluid environment of the wound bed. The ECM is a complex network of proteins such as collagen, elastin, and fibronectin that provides physical scaffolding for cells and regulates biological processes like adhesion and migration (Source: NIH/NCBI). Wound exudate is the liquid produced by wounds that contains essential nutrients, growth factors, and immune cells necessary for healing (Source: PubMed). In chronic wounds, the balance of these components is often disrupted, leading to an overabundance of matrix metalloproteinases (MMPs) that prematurely degrade the ECM and inhibit tissue repair (Source: StatPearls). Therapeutic interventions often target these components through enzymatic debridement, such as using collagenase to remove necrotic tissue, or through advanced dressings that manage exudate levels and neutralize harmful proteases (Source: Journal of Wound Care). Understanding the interplay between the ECM and exudate is critical for developing treatments for non-healing ulcers and fibrotic conditions (Source: Nature Reviews Molecular Cell Biology). These components are not single molecular targets but rather a heterogeneous mixture of proteins and fluids that define the local physiological state of a wound. Drugs interacting with this environment often aim to restore homeostasis by either supplementing missing factors or removing inhibitory substances.
Enzymatic debridement of necrotic tissue, modulation of protease activity, and maintenance of a moist environment to facilitate autolytic debridement and granulation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular matrix proteins and wound exudate components.